Simran Gulati

MD Radiation oncology

[Priyamvada Maitre @docpriyamvada]

🤩 Finally OUT in @JCO_ASCO!

BART RCT from 🇮🇳 largest ph3 for adjuvant RT in high risk MIBC post cystectomy

A decade of persistence from @VedangMurthy ☺️
@RadOncTMC @TataMemorial @ACTREC_TMC
@PaulSargos
@Xristodouleas

https://t.co/B8iTgImLHr

[Vedang Murthy @VedangMurthy]

Very proud of my whole team esp @indranilsays for brilliantly presenting the 1y AE data of the largest RCT in HR and N+ CaP.
SBRT is safe! Gr 3 AE very low.
More to follow....

[TMC Radiation Oncology @RadOncTMC]

@ESTRO_RT @JifmiM @dr_samdavid @AnuradhaaKrish @Dr_ArunimaNagar @Supriya_Sastri @VedangMurthy @DrVasanthapriya @Suman_radonc @ReenaEngineer @AshwiniBudrukar Proffered Paper at ESTRO 2026

Dr Tejpal Gupta from Team NEuro Oncology @RadOncTMC presented outcomes of de-escalated radiotherapy with low-dose CSI followed by chemotherapy in low-risk WNT-pathway medulloblastoma.

#ESTRO2026 #Medulloblastoma #PaediatricOncology #RadOnc

[Simran Gulati @SimranGula45676]

@MyNykaa my order has been shown as delivered but I have not received it. I have raised this complaint multiple times in the last week but have not been given any solution. Kindly look into this urgently.

[TMC Radiation Oncology @RadOncTMC]

Honored to share highlights of @ReenaEngineer’s presentation of POLCAGB phase III trial at #ASCO2025, a game changer for locally advanced gallbladder cancer
Neoadj CRT vs CT alone:
🌟 Nearly doubled mOS (21.8 vs 10.1 months)
🌟 Significantly improved R0 resection (51.6% vs 29.7%)

[Stefano Arcangeli @StAr_MCM74]

🚀 oustanding presentation by @VedangMurthy showing that #AUGMENTED RT ⬆️ outcomes with extremely limited tox in high-risk PCa

#ESTRO2025